Global Clinical Trials Market Outlook to 2031 –

0

Dublin, May 06, 2022 (GLOBE NEWSWIRE) — The report “Global Clinical Trials Market 2021-2031 by Product Category, Phase, Design, Service Type, Indication, End User and Region” has been added to from ResearchAndMarkets.com offer.

The global clinical trials market will reach $79,977.1 million by 2031, growing at 6.8% pa over the period 2021-2031, driven by the growing number of clinical trials and the increase in demand for new therapies, the growing prevalence of chronic diseases such as cancer and diabetes, the epidemic of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments.

The report is based on extensive research of the entire Global Clinical Trials Market and all its sub-segments through highly detailed classifications. In-depth analyzes and assessments are generated from premium primary and secondary information sources with input from industry professionals across the value chain. The report is based on studies from 2018-2021 and provides forecasts from 2022 to 2031 with 2021 as the base year.

In-depth qualitative analyzes include the identification and investigation of the following aspects:

  • Market structure
  • Growth engines
  • Constraints and challenges
  • Emerging Product Trends and Market Opportunities
  • Porter’s Five Forces

The global market trend and outlook is forecasted in an optimistic, balanced and conservative view considering COVID-19. The balanced (most probable) projection is used to quantify the global clinical trials market in all aspects of classification from the perspective of product category, phase, design, service type, indication, end user and region.

On the basis of product category, the global market is segmented into the following sub-markets with annual revenue (USD Million) for 2021-2031 included in each section.

  • Drug trials
  • Small molecule drugs
  • Vaccines
  • Cell and gene therapy
  • Other drugs
  • Device tests
  • Procedural trials

On the basis of Phase, the global market is segmented into the following sub-markets with annual revenue (USD Million) for 2021-2031 included in each section.

  • Phase I
  • Stage II
  • Phase III
  • Phase IV

By design, the global market is segmented into the following sub-markets with annual revenue (USD Million) for 2021-2031 included in each section.

  • Interventional studies
  • Randomized control trial
  • Adaptive clinical trial
  • Non-randomized control trial
  • Observational studies
  • Cohort study
  • Case-control study
  • Cross-sectional study
  • Ecological study
  • Extended Access Trials

By type of service, the global market is segmented into the following sub-markets with annual revenue (USD Million) for 2021-2031 included in each section.

  • Protocol design
  • Site identification
  • Patient recruitment
  • Laboratory services
  • Bioanalytical Testing Services
  • Clinical Trial Data Management Services
  • Provision of clinical trials and logistics services
  • Decentralized Clinical Trial Services
  • Medical Device Testing Services
  • Other clinical trial services

By indication, the global market is segmented into the following sub-markets with annual revenue (USD Million) for 2021-2031 included in each section.

  • Oncology
  • Infectious diseases
  • Cardiology
  • Obesity
  • Diabetes
  • Neurology
  • Immunology
  • pain management
  • Other indications

By end-user, the global market is segmented into the following sub-markets with annual revenue (USD Million) for 2021-2031 included in each section.

  • Pharmaceutical and biotechnology companies
  • Clinical research organizations
  • Clinical Trial Laboratories
  • Other end users

Geographically, the following regions as well as national/local markets listed are fully investigated:

  • North America (United States, Canada and Mexico)
  • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark and Finland)
  • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
  • South America (Brazil, Chile, Argentina, Rest of South America)
  • MEA (UAE, Saudi Arabia, South Africa, Other Nations)

For each region and country mentioned above, detailed analysis and annual revenue data (in millions of dollars) are available for 2021-2031. The breakdown of all regional markets by country and the breakdown of major national markets by phase, design and indication over the forecast years are also included.

The report also covers the current competitive scenario and the forecasted trend; and profiles key vendors, including market leaders and important emerging players.

Main topics covered:

1. Introduction

2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on the global economy
2.1.2 Impact of COVID-19 on the market
2.2 Key Growth Drivers
2.3 Market Constraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Five Forces Analysis

3 Global Market Segmentation by Product Category
3.1 Market Overview by Product Category
3.2 Drug trials
3.2.1 Small molecule drugs
3.2.2 Vaccines
3.2.3 Cell and gene therapy
3.2.4 Other drugs
3.3 Device tests
3.4 Procedural trials

4 Global Market Segmentation by Phase
4.1 Market Overview by Phase
4.2 Stage I
4.3 Phase II
4.4 Phase III
4.5 Phase IV

5 Global Market Segmentation by Design
5.1 Market Overview by Design
5.2 Intervention studies
5.2.1 Randomized controlled trial
5.2.2 Adaptive clinical trial
5.2.3 Non-randomized control trial
5.3 Observational studies
5.3.1 Cohort study
5.3.2 Case-control study
5.3.3 Cross-sectional study
5.3.4 Ecological study
5.4 Extended Access Tests

6 Global Market Segmentation by Service Type
6.1 Market Overview by Service Type
6.2 Protocol design
6.3 Site Identification
6.4 Patient recruitment
6.5 Laboratory Services
6.6 Bioanalytical Testing Services
6.7 Clinical Trial Data Management Services
6.8 Provision of Clinical Trials and Logistics Services
6.9 Decentralized Clinical Trial Services
6.10 Medical Device Testing Services
6.11 Other clinical trial services

7 Global Market Segmentation by Indication
7.1 Market Overview by Indication
7.2 Oncology
7.3 Infectious diseases
7.4 Cardiology
7.5 Obesity
7.6 Diabetes
7.7 Neurology
7.8 Immunology
7.9 Pain management
7.10 Other indications

8 Global Market Segmentation by End User
8.1 Market Overview by End User
8.2 Pharmaceutical and biotechnology companies
8.3 Clinical research organizations
8.4 Clinical Trial Laboratories
8.5 Other end users

9 Global Market Segmentation by Region
9.1 Geographic Market Overview 2021-2031
9.2 2021-2031 North America Market by Country
9.2.1 North America Market Overview
9.2.2 United States
9.2.3 Canada
9.2.4 Mexico
9.3 Europe Market 2021-2031 by Country
9.3.1 European Market Overview
9.3.2 Germany
9.3.3 United Kingdom
9.3.4 France
9.3.5 Spain
9.3.6 Italy
9.3.7 Russia
9.3.8 Rest of the European market
9.4 Asia-Pacific Market 2021-2031 by Country
9.4.1 Asia Pacific Market Overview
9.4.2 Japan
9.4.3 China
9.4.4 Australia
9.4.5 India
9.4.6 South Korea
9.4.7 Rest of APAC
9.5 2021-2031 South America Market by Country
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America Market
9.6 MEA Market 2021-2031 by Country
9.6.1 WATER
9.6.2 Saudi Arabia
9.6.3 South Africa
9.6.4 Other national markets

10 Competitive Landscape
10.1 Major Vendors Overview
10.2 New Product Launch, Partnership, Investment, and Mergers and Acquisitions
10.3 Company Profiles

  • Accell Clinical Research LLC
  • Charles River Laboratory
  • ClinDatrix Inc
  • Clinipace
  • Eli Lilly and company
  • F. Hoffmann-La Roche Ltd.
  • PLC ICON
  • IQVIA Holdings, Inc.
  • Laboratory Society of America
  • Novo Nordisk AS
  • PAREXEL International Corporation
  • Pfizer Inc.
  • Pharmaceutical Product Development LLC
  • PRA Health Sciences
  • Sanofi SA
  • SGS S.A.
  • Syneos Health Inc.
  • Wuxi AppTec Inc.

For more information about this report visit https://www.researchandmarkets.com/r/lulptq

  • Global Clinical Trials Market



Source link

Share.

About Author

Comments are closed.